Reprogramming cancer cells to treat acute myelogenous leukemia – BioNews Central A new combination therapy alters gene activity to reduce stem cell-like traits and promote cell differentiation, offering potential therapeutic benefits for acute myelogenous leukemia (AML). ...

A new #CombinationTherapy alters #GeneActivity to reduce #StemCell -like traits and promote #CellDifferentiation, offering potential therapeutic benefits for #AcuteMyelogenousLeukemia (#AML).